Overview

Topical Oxybutynin for Treatment of Hyperidrosis: a Local or a Systemic Effect?

Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The TODAY trial is a study to evaluate the efficacy and safety of topical oxybutynin deodorant for use in patients with axillary hyperhidrosis.
Phase:
Phase 2
Details
Lead Sponsor:
Samantha Rodrigues Camargo Neves de Moura
Collaborator:
Science Valley Research Institute
Treatments:
Mandelic Acids
Oxybutynin